Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 18, 2017 - Issue 8
Submit an article Journal homepage
351
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan

Yasushi TsujiDepartment of Medical Oncology, Tonan Hospital, Sapporo, JapanCorrespondence[email protected]
,
Hideo BabaDepartment of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan
,
Koji TakedaDepartment of Clinical Oncology, Osaka City General Hospital, Osaka, Japan
,
Michiya KobayashiCancer Treatment Center, Kochi Medical School Hospital, Nankoku, Japan
,
Eiji OkiDepartment of Surgery and Science, Kyushu University, Fukuoka, Japan
,
Masahiro GotohCancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan
,
Kazuhiro YoshidaDepartment of Surgical Oncology, Gifu University, Gifu, Japan
,
Mototsugu ShimokawaDepartment of Cancer Information Research, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
,
Yoshihiro KakejiDivision of Gastrointestinal Surgery, Kobe University Hospital, Kobe, Japan
&
Keisuke AibaDepartment of Internal Medicine, Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan
 show all
Pages 753-758 | Received 01 Dec 2016, Accepted 06 Apr 2017, Published online: 21 Apr 2017

References

  • World Health Organization. Cancer Fact sheet Nº297, Updated Feb 2015. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/
  • Thirion P, Michiels S, Piedbois P, et al. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol. 2004;22(18):3766–3775.
  • Tournigand C, André T, De Gramont A, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22(2):229–237.
  • Yamazaki K, Nagase M, Hyodo I, et al. Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G). Ann Oncol. 2016;27:1539–1546.
  • Neymark N, Crott R. Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer. 2005 Oct;13(10):812–818.
  • Basch E, Prestrud AA, Lyman GH, et al. American society of clinical oncology. Antiemetics: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2011;29(31):4189–4198.
  • Roila F, Herrstedt J, Warr D, et al. Guideline update for for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol. 2010;21(Suppl 5):v232–v243.
  • NCCN clinical practice guidelines in oncology. Antiemesis. Version 2, NCCN.Org. 2014. Available from: https://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf
  • Japan Society of Clinical Oncology. Guidelines for appropriate use of antiemetic drugs, version 1. Tokyo: Kanehara; 2010.
  • Tamura K, Aiba K, Saeki T, et al. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV study group of Japan. Int J Clin Oncol. 2015;20(5):855–865.
  • André T, Boni C, De Gramont A, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109–3116.
  • Haller DG, Tabernero J, Schmoll HJ, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29:1465–1471.
  • Nishimura J, Satoh T, Mori M, et al. Multi-center clinical study group of Osaka, Colorectal Cancer Treatment Group (MCSGO). Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial. Eur J Cancer. 2015;51(10):1274–1282.
  • Saito M, Aogi K, Mitsuhashi S, et al. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol. 2009;10(2):115–124.
  • Kitayama H, Tsuji Y, Hirayama M, et al. Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study. Int J Clin Oncol. 2015;20(6):1051–1056.
  • Sekine I, Segawa Y, Saeki T, et al. Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis. Cancer Sci. 2013;104(6):711–717.
  • Roila F, Hesketh PJ, Herrstedt J. Antiemetic subcommitte of the multinational association of supportive care in cancer. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol. 2006;17(1):20–28.
  • Du Bois A, Meerpohl HG, Pfleiderer A, et al. Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron. Eur J Cancer. 1992;28(2–3):450–457.
  • Cisplatin-induced delayed emesis: pattern and prognostic factors during three subsequent cycles. Italian group for antiemetic research. Ann Oncol. 1994;5(7):585–589.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.